BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1377555)

  • 1. Deuterium nuclear magnetic resonance imaging of the developmental pattern of tumour blood flow.
    Burney IA; Maxwell RJ; Griffiths JR; Field SB
    EXS; 1992; 61():357-61. PubMed ID: 1377555
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiogenesis determines blood flow, metabolism, growth rate, and ATPase kinetics of tumors growing in an irradiated bed: 31P and 2H nuclear magnetic resonance studies.
    Okunieff P; Dols S; Lee J; Singer S; Vaupel P; Neuringer LJ; Beshah K
    Cancer Res; 1991 Jun; 51(12):3289-95. PubMed ID: 1710169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of murine radiation-induced fibrosarcoma-1 tumor metabolism and blood flow in situ via glucose and mannitol administration monitored by 31P and 2H nuclear magnetic resonance spectroscopy.
    Hwang YC; Kim SG; Evelhoch JL; Seyedsadr M; Ackerman JJ
    Cancer Res; 1991 Jun; 51(12):3108-18. PubMed ID: 1904001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxygenation and bioenergetic status of murine fibrosarcomas.
    Schaefer C; Okunieff P; Vaupel P
    Adv Exp Med Biol; 1992; 317():161-7. PubMed ID: 1288123
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of prostaglandin synthesis inhibitors on tumor growth and vascularization. Experimental studies in the rat.
    Peterson HI
    Invasion Metastasis; 1983; 3(3):151-9. PubMed ID: 6203870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The perfluorocarbon emulsion PFOB: potential indicator of change in blood volume using fluorine-19 NMR spectroscopy.
    Thomas C; Counsell C; Sansom J; Wood P; Stratford I; Adams G
    EXS; 1992; 61():362-7. PubMed ID: 1377556
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor size dependent changes in a murine fibrosarcoma: use of in vivo 31P NMR for non-invasive evaluation of tumor metabolic status.
    Okunieff PG; Koutcher JA; Gerweck L; McFarland E; Hitzig B; Urano M; Brady T; Neuringer L; Suit HD
    Int J Radiat Oncol Biol Phys; 1986 May; 12(5):793-9. PubMed ID: 3710861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced blood flow increases the in vivo ammonium ion concentration in the RIF-1 tumor.
    Constantinidis I; Gamcsik MP
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):143-9. PubMed ID: 7642412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance spectroscopic studies on 'real-time' changes in RIF-1 tumour metabolism and blood flow during and after photodynamic therapy.
    Bremner JC; Bradley JK; Stratford IJ; Adams GE
    Br J Cancer; 1994 Jun; 69(6):1083-7. PubMed ID: 8198974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for intermittent radiobiological hypoxia in experimental tumour systems.
    Chaplin DJ; Trotter MJ; Durand RE; Olive PL; Minchinton AI
    Biomed Biochim Acta; 1989; 48(2-3):S255-9. PubMed ID: 2730619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deuterium magnetic resonance in vivo: the measurement of blood flow and tissue perfusion.
    Ackerman JJ; Ewy CS; Kim SG; Shalwitz RA
    Ann N Y Acad Sci; 1987; 508():89-98. PubMed ID: 3439714
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of vasoactive drugs on tumour blood flow as determined by 2H nuclear magnetic resonance spectroscopy.
    Burney IA; Maxwell RJ; Field SB; McCoy CL; Griffiths JR
    Acta Oncol; 1995; 34(3):367-71. PubMed ID: 7779425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of vasoactive drugs on local tumor blood flow.
    Mattsson J; Lilja J; Peterson HI
    Eur J Cancer Clin Oncol; 1982 Jul; 18(7):677-84. PubMed ID: 6889968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of vasoactive drugs on the intratumor distribution of blood flow and vascular volume in a transplantable rat fibrosarcoma.
    Karlsson L; Alpsten A; Mattsson J; Peterson HI
    J Cancer Res Clin Oncol; 1983; 105(3):212-20. PubMed ID: 6853584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma.
    Kandel J; Bossy-Wetzel E; Radvanyi F; Klagsbrun M; Folkman J; Hanahan D
    Cell; 1991 Sep; 66(6):1095-104. PubMed ID: 1717155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear magnetic resonance imaging of a fibrosarcoma tumor implanted in the rat.
    Moon KL; Davis PL; Kaufman L; Crooks LE; Sheldon PE; Miller T; Brito AC; Watts JC
    Radiology; 1983 Jul; 148(1):177-81. PubMed ID: 6856831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of solid tumor growth by a monoclonal antibody against tumor vasculature in rats: involvement of intravascular thrombosis and fibrinogenesis.
    Ohizumi I; Taniguchi K; Saito H; Kawata H; Tsunoda S; Makimoto H; Wakai Y; Tsutsumi Y; Nakagawa S; Utoguchi N; Kaiho S; Ohsugi Y; Mayumi T
    Int J Cancer; 1999 Sep; 82(6):853-9. PubMed ID: 10446453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonglycolytic acidification of murine radiation-induced fibrosarcoma 1 tumor via 3-O-methyl-D-glucose monitored by 1H, 2H, 13C, and 31P nuclear magnetic resonance spectroscopy.
    Hwang YY; Kim SG; Evelhoch JL; Ackerman JJ
    Cancer Res; 1992 Mar; 52(5):1259-66. PubMed ID: 1737388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurements of tumor blood flow using intraperitoneal deuterium and 2H-NMR spectroscopy.
    Okunieff P; Lee J; Itoh M; Vaupel P
    Adv Exp Med Biol; 1992; 316():373-83. PubMed ID: 1288098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 31P nuclear magnetic resonance measurements of ATPase kinetics in malignant tumors.
    Okunieff P; Vaupel P; Neuringer LJ
    Adv Exp Med Biol; 1989; 248():819-27. PubMed ID: 2528893
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.